# Sabra Health Care REIT, Inc.: filings

SBRA · Nasdaq · CIK 1492298 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbra.md) · [Financials](/companies/sbra/financials.md) · [Filings](/companies/sbra/filings.md) · [Insiders](/companies/sbra/insiders.md)

## Reports and events: 330 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 964, 8-K 241, SC 13G/A 60, 10-Q 48, 424B5 32, UPLOAD 23, CORRESP 21, DEFA14A 18, 3 17, 10-K 16, DEF 14A 16, 425 15, SC 13G 12, 4/A 10, ARS 8, FWP 7, S-4/A 7, 8-K/A 6, EFFECT 6, S-3ASR 5, 424B3 4, S-4 4, S-8 4, 10-K/A 3, POSASR 3, SCHEDULE 13G/A 3, 144 2, 5 2, 8-A12B 2, CERTNAS 2, SCHEDULE 13G 2, 25-NSE 1, 3/A 1, 424B4 1, PRE 14A 1, S-11 1, S-11/A 1, S-11MEF 1, S-3 1, S-3/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-03 | 16:06 ET | [10-Q](/filings/0001492298-26-000028.md) | Quarterly report, period 2026-06-30 | 0001492298-26-000028 |
| 2026-08-03 | 16:05 ET | [8-K](/filings/0001492298-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000027 |
| 2026-07-21 | 09:05 ET | [8-K](/filings/0001492298-26-000023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000023 |
| 2026-06-17 | 16:40 ET | [8-K](/filings/0001492298-26-000019.md) | 5.07 Shareholder vote results | 0001492298-26-000019 |
| 2026-05-28 | 16:05 ET | [8-K](/filings/0001492298-26-000014.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000014 |
| 2026-04-29 | 16:06 ET | [10-Q](/filings/0001492298-26-000012.md) | Quarterly report, period 2026-03-31 | 0001492298-26-000012 |
| 2026-04-29 | 16:05 ET | [8-K](/filings/0001492298-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000011 |
| 2026-04-24 | 09:06 ET | [DEF 14A](/filings/0001193125-26-175398.md) | Proxy statement, period 2026-06-17 | 0001193125-26-175398 |
| 2026-02-12 | 16:07 ET | [10-K](/filings/0001492298-26-000008.md) | Annual report, period 2025-12-31 | 0001492298-26-000008 |
| 2026-02-12 | 16:05 ET | [8-K](/filings/0001492298-26-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000007 |
| 2026-01-05 | 09:15 ET | [8-K](/filings/0001492298-26-000002.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000002 |
| 2025-11-05 | 16:09 ET | [10-Q](/filings/0001492298-25-000039.md) | Quarterly report, period 2025-09-30 | 0001492298-25-000039 |
| 2025-11-05 | 16:06 ET | [8-K](/filings/0001492298-25-000038.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000038 |
| 2025-08-05 | 17:16 ET | [8-K](/filings/0001193125-25-173630.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-173630 |
| 2025-08-04 | 16:07 ET | [10-Q](/filings/0001492298-25-000031.md) | Quarterly report, period 2025-06-30 | 0001492298-25-000031 |
| 2025-08-04 | 16:05 ET | [8-K](/filings/0001492298-25-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000030 |
| 2025-07-31 | 16:06 ET | [8-K](/filings/0001492298-25-000027.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001492298-25-000027 |
| 2025-06-30 | 16:05 ET | [8-K](/filings/0001492298-25-000025.md) | 8.01 Other events | 0001492298-25-000025 |
| 2025-06-12 | 16:18 ET | [8-K](/filings/0001492298-25-000018.md) | 5.07 Shareholder vote results | 0001492298-25-000018 |
| 2025-05-05 | 16:06 ET | [10-Q](/filings/0001492298-25-000016.md) | Quarterly report, period 2025-03-31 | 0001492298-25-000016 |
| 2025-05-05 | 16:05 ET | [8-K](/filings/0001492298-25-000015.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000015 |
| 2025-04-25 | 09:00 ET | [DEF 14A](/filings/0001193125-25-095172.md) | Proxy statement, period 2025-06-12 | 0001193125-25-095172 |
| 2025-03-24 | 09:20 ET | [8-K](/filings/0001492298-25-000011.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000011 |
| 2025-02-19 | 16:07 ET | [10-K](/filings/0001492298-25-000008.md) | Annual report, period 2024-12-31 | 0001492298-25-000008 |
| 2025-02-19 | 16:05 ET | [8-K](/filings/0001492298-25-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000007 |
| 2024-11-12 | 09:20 ET | [8-K](/filings/0001492298-24-000033.md) | 5.02 Departure or appointment of officers or directors | 0001492298-24-000033 |
| 2024-10-31 | 16:06 ET | [10-Q](/filings/0001492298-24-000031.md) | Quarterly report, period 2024-09-30 | 0001492298-24-000031 |
| 2024-10-31 | 16:05 ET | [8-K](/filings/0001492298-24-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000030 |
| 2024-08-07 | 16:08 ET | [10-Q](/filings/0001492298-24-000025.md) | Quarterly report, period 2024-06-30 | 0001492298-24-000025 |
| 2024-08-07 | 16:06 ET | [8-K](/filings/0001492298-24-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000024 |
| 2024-06-13 | 17:20 ET | [8-K](/filings/0001492298-24-000017.md) | 5.07 Shareholder vote results | 0001492298-24-000017 |
| 2024-05-08 | 16:07 ET | [10-Q](/filings/0001492298-24-000014.md) | Quarterly report, period 2024-03-31 | 0001492298-24-000014 |
| 2024-05-08 | 16:06 ET | [8-K](/filings/0001492298-24-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000013 |
| 2024-04-26 | 09:01 ET | [DEF 14A](/filings/0001193125-24-116049.md) | Proxy statement, period 2024-06-13 | 0001193125-24-116049 |
| 2024-02-27 | 16:08 ET | [10-K](/filings/0001492298-24-000008.md) | Annual report, period 2023-12-31 | 0001492298-24-000008 |
| 2024-02-27 | 16:06 ET | [8-K](/filings/0001492298-24-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000007 |
| 2024-01-04 | 09:15 ET | [8-K](/filings/0001492298-24-000003.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000003 |
| 2023-11-06 | 16:07 ET | [10-Q](/filings/0001492298-23-000025.md) | Quarterly report, period 2023-09-30 | 0001492298-23-000025 |
| 2023-11-06 | 16:06 ET | [8-K](/filings/0001492298-23-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000024 |
| 2023-08-07 | 16:07 ET | [10-Q](/filings/0001492298-23-000021.md) | Quarterly report, period 2023-06-30 | 0001492298-23-000021 |
| 2023-08-07 | 16:06 ET | [8-K](/filings/0001492298-23-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000020 |
| 2023-06-14 | 16:45 ET | [8-K](/filings/0001492298-23-000016.md) | 5.07 Shareholder vote results | 0001492298-23-000016 |
| 2023-05-03 | 16:07 ET | [10-Q](/filings/0001492298-23-000014.md) | Quarterly report, period 2023-03-31 | 0001492298-23-000014 |
| 2023-05-03 | 16:05 ET | [8-K](/filings/0001492298-23-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000013 |
| 2023-04-24 | 09:03 ET | [DEF 14A](/filings/0001193125-23-111909.md) | Proxy statement | 0001193125-23-111909 |
| 2023-03-20 | 16:05 ET | [10-K/A](/filings/0001492298-23-000008.md) | Annual report, amended, period 2022-12-31 | 0001492298-23-000008 |
| 2023-02-23 | 09:07 ET | [8-K](/filings/0001193125-23-045742.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-045742 |
| 2023-02-21 | 16:09 ET | [10-K](/filings/0001492298-23-000006.md) | Annual report, period 2022-12-31 | 0001492298-23-000006 |
| 2023-02-21 | 16:06 ET | [8-K](/filings/0001492298-23-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000005 |
| 2023-01-05 | 09:05 ET | [8-K](/filings/0001193125-23-002031.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-002031 |

Page 1 of 7. [Older](/companies/sbra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.